{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:26:33Z","timestamp":1783441593142,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["7262137"],"award-info":[{"award-number":["7262137"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025MS1261"],"award-info":[{"award-number":["ZR2025MS1261"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Peking University People\u2019s Hospital Research and Development Funds","award":["RDJP2025-20"],"award-info":[{"award-number":["RDJP2025-20"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10067-026-08200-0","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:42:19Z","timestamp":1780929739000},"page":"4325-4333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytokine profiling reveals distinct inflammatory clusters and clinical correlations in antiphospholipid syndrome"],"prefix":"10.1007","volume":"45","author":[{"given":"Xiangjun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8885-7452","authenticated-orcid":false,"given":"Yuzhou","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"8200_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069717","volume":"380","author":"JS Knight","year":"2023","unstructured":"Knight JS, Branch DW, Ortel TL (2023) Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ 380:e069717","journal-title":"BMJ"},{"issue":"2","key":"8200_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295\u2013306","journal-title":"J Thromb Haemost"},{"issue":"10","key":"8200_CR3","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.42624","volume":"75","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R et al (2023) The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol 75(10):1687\u20131702","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"8200_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/BOR.0000000000000926","volume":"35","author":"A Ambati","year":"2023","unstructured":"Ambati A, Zuo Y, Knight JS (2023) An update on inflammation in antiphospholipid syndrome. Curr Opin Rheumatol 35(2):89\u201397","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"8200_CR5","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s11239-020-02155-y","volume":"50","author":"FT Arantes","year":"2020","unstructured":"Arantes FT, Mazetto BM, Saraiva SS et al (2020) Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome. J Thromb Thrombolysis 50(4):772\u2013781","journal-title":"J Thromb Thrombolysis"},{"issue":"9","key":"8200_CR6","first-page":"1875","volume":"41","author":"CM Yelnik","year":"2023","unstructured":"Yelnik CM, Lambert M, Drumez E et al (2023) Relevance of inflammatory and complement activation biomarkers profiling in antiphospholipid syndrome patients outside acute thrombosis. Clin Exp Rheumatol 41(9):1875\u20131881","journal-title":"Clin Exp Rheumatol"},{"issue":"Sup1","key":"8200_CR7","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1182\/blood-2023-187962","volume":"142","author":"AK Hubben","year":"2023","unstructured":"Hubben AK, Bazeley P, Swaidani S et al (2023) Cytokine profiling in antiphospholipid syndrome demonstrates persistent immune dysregulation and a procoagulant phenotype. Blood 142(Sup1):3","journal-title":"Blood"},{"issue":"6","key":"8200_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/CM9.0000000000001964","volume":"135","author":"C Li","year":"2022","unstructured":"Li C, Zuo Y, Zhang S, Makris UE, Karp DR, Li Z (2022) Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients. Chin Med J (Engl) 135(6):658\u2013664","journal-title":"Chin Med J (Engl)"},{"issue":"8","key":"8200_CR9","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/rheumatology\/kes388","volume":"52","author":"S Sciascia","year":"2013","unstructured":"Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML (2013) GAPSS: the global anti-phospholipid syndrome score. Rheumatology (Oxford) 52(8):1397\u20131403","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8200_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.semarthrit.2019.04.009","volume":"49","author":"M Radin","year":"2019","unstructured":"Radin M, Sciascia S, Erkan D et al (2019) The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: results from the APS ACTION cohort. Semin Arthritis Rheum 49(3):464\u2013468","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"8200_CR11","first-page":"503","volume":"10","author":"K Ahmed","year":"1992","unstructured":"Ahmed K, Vianna JL, Khamashta MA, Hughes GR (1992) IL-2, IL-6 and TNF levels in primary antiphospholipid syndrome. Clin Exp Rheumatol 10(5):503","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"8200_CR12","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.autrev.2017.09.012","volume":"16","author":"KH Lee","year":"2017","unstructured":"Lee KH, Kronbichler A, Park DD, Park DD-Y, Park Y, Lee D, Lee SY, Lee S et al (2017) Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review. Autoimmun Rev 16(11):1160\u20131173","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8200_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2025.150909","volume":"40","author":"A Butt","year":"2025","unstructured":"Butt A, Sharda A, Lee AI, Knight JS (2025) Analytical review: neutrophil extracellular traps and antiphospholipid syndrome. Transfus Med Rev 40(1):150909","journal-title":"Transfus Med Rev"},{"key":"8200_CR14","doi-asserted-by":"crossref","unstructured":"Knight JS, Meng H, Coit P et al (2017) Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target. JCI Insight 2(18):e93897","DOI":"10.1172\/jci.insight.93897"},{"issue":"10","key":"8200_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048111","volume":"7","author":"RS Keshari","year":"2012","unstructured":"Keshari RS, Jyoti A, Dubey M et al (2012) Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition. PLoS One 7(10):e48111","journal-title":"PLoS One"},{"issue":"4","key":"8200_CR16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","volume":"50","author":"ED Tait Wojno","year":"2019","unstructured":"Tait Wojno ED, Hunter CA, Stumhofer JS (2019) The immunobiology of the interleukin-12 family: room for discovery. Immunity 50(4):851\u2013870","journal-title":"Immunity"},{"issue":"9","key":"8200_CR17","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/ard-2024-225664","volume":"83","author":"D Nikolopoulos","year":"2024","unstructured":"Nikolopoulos D, Loukogiannaki C, Sentis G et al (2024) Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events. Ann Rheum Dis 83(9):1132\u20131143","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8200_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1055\/s-0037-1615676","volume":"85","author":"ML Bertolaccini","year":"2001","unstructured":"Bertolaccini ML, Atsumi T, Lanchbury JS et al (2001) Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost 85(2):198\u2013203","journal-title":"Thromb Haemost"},{"issue":"3","key":"8200_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00296-009-1314-8","volume":"31","author":"J Swadzba","year":"2011","unstructured":"Swadzba J, Iwaniec T, Musial J (2011) Increased level of tumor necrosis factor-\u03b1 in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state. Rheumatol Int 31(3):307\u2013313","journal-title":"Rheumatol Int"},{"issue":"4","key":"8200_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain DW, Cidlowski JA (2017) Immune regulation by glucocorticoids. Nat Rev Immunol 17(4):233\u2013247","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8200_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335(1):2\u201313","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"8200_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","volume":"74","author":"I Raphael","year":"2015","unstructured":"Raphael I, Nalawade S, Eagar TN, Forsthuber TGT (2015) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74(1):5\u201317","journal-title":"Cytokine"},{"issue":"2","key":"8200_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.mcna.2016.09.005","volume":"101","author":"PG Fraenkel","year":"2017","unstructured":"Fraenkel PG (2017) Anemia of inflammation. Med Clin North Am 101(2):285\u2013296","journal-title":"Med Clin North Am"},{"key":"8200_CR24","doi-asserted-by":"publisher","first-page":"108259","DOI":"10.1016\/j.clim.2019.108259","volume":"208","author":"M Wang","year":"2019","unstructured":"Wang M, Zhang P, Yu S, Wang Q et al (2019) Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss. Clin Immunol 208:108259","journal-title":"Clin Immunol"},{"issue":"3","key":"8200_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/BOR.0000000000000932","volume":"35","author":"A Ambati","year":"2023","unstructured":"Ambati A, Knight JS, Zuo Y (2023) Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach. Curr Opin Rheumatol 35(3):149\u2013160","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"8200_CR26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jtha.2022.12.002","volume":"21","author":"DM Salet","year":"2023","unstructured":"Salet DM, Bekkering S, Middeldorp S, van den Hoogen LL (2023) Targeting thromboinflammation in antiphospholipid syndrome. J Thromb Haemost 21(4):744\u2013757","journal-title":"J Thromb Haemost"},{"issue":"4","key":"8200_CR27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/1573397116666200116095734","volume":"16","author":"GA El-Moniem","year":"2020","unstructured":"El-Moniem GA, El-Garf K, Sobhy N, Elmaghraby S (2020) Characterization of the clinical and laboratory features of primary and secondary antiphospholipid syndrome in a cohort of Egyptian patients. Curr Rheumatol Rev 16(4):304\u2013310","journal-title":"Curr Rheumatol Rev"},{"issue":"1","key":"8200_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12884-018-1850-x","volume":"18","author":"PK Bundhun","year":"2018","unstructured":"Bundhun PK, Soogund M, Huang F (2018) Arterial\/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis. BMC Pregnancy Childbirth 18(1):212","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"8200_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1055\/s-0028-1082265","volume":"34","author":"EN Harris","year":"2008","unstructured":"Harris EN, Pierangeli SS (2008) Primary, secondary, and catastrophic antiphospholipid syndrome: what\u2019s in a name. Semin Thromb Hemost 34(3):219\u2013226","journal-title":"Semin Thromb Hemost"},{"key":"8200_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.702425","volume":"12","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, You Y, Wang F, Wang M et al (2021) Urine proteomics differentiate primary thrombotic antiphospholipid syndrome from obstetric antiphospholipid syndrome. Front Immunol 12:702425","journal-title":"Front Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08200-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08200-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08200-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:02:43Z","timestamp":1783440163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08200-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8200"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08200-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}